Informa
TIDES Asia: Oligonucleotide & Peptide Therapeutics
2026年2月24-26日
日本, 東京, Grand Nikko Tokyo Daiba

會前研討會（上午） & 主要會議第1天（下午）

會前研討會（上午） & 主要會議第1天（下午）
Optional Pre-Conference Workshops
會前研討會（可選）
8:00am - 9:00am60 分
Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
研討會1：新型RNA化學的相關法規和現實CMC考慮因素
Registration and Coffee
報到與咖啡時光
    8:00am - 9:00am60 分
    Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
    研討會2：長肽和/或複雜肽的製造和表徵
    Registration and Coffee
    報到與咖啡時光
      9:00am - 9:10am10 分
      Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
      研討會1：新型RNA化學的相關法規和現實CMC考慮因素
      Workshop Moderator's Opening Remarks: Workshop #1
      研討會主持人致開幕詞：研討會1
      • Thomas Rupp - Owner & Principal, Thomas Rupp Consulting
      9:00am - 9:10am10 分
      Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
      研討會2：長肽和/或複雜肽的製造和表徵
      Workshop Moderator's Opening Remarks: Workshop #2
      研討會主持人致開幕詞：研討會2
      • Bruce Morimoto, PhD - Independent Consultant, TIDES Advisor
      9:10am - 9:55am45 分
      Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
      研討會1：新型RNA化學的相關法規和現實CMC考慮因素
      Manufacturing and Upscale Challenges of Next-generation Oligonucleotide Therapeutics
      製造和升級下一代寡核苷酸藥物的課題
      • Chris Oswald - Founder, Owner, and Principal Consultant, Coswald Consulting LLC
      9:10am - 9:55am45 分
      Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
      研討會2：長肽和/或複雜肽的製造和表徵
      Strategies for Manufacturing of Long and Complex Peptides: Technical Considerations and Case Studies
      長肽及複雜肽的製造策略：技術考量與案例研究
      • Robert Hagopian - Global Director, Biotech Partnerships, PolyPeptide Group
      • El Djouhar Rekaï, PhD - Head of Peptide Process Development & Manufacturing, PolyPeptide Group
      9:55am - 10:40am45 分
      Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
      研討會1：新型RNA化學的相關法規和現實CMC考慮因素
      Process-related Impurities of Next-generation Oligonucleotide Therapeutics
      下一代寡核苷酸治療藥物的製程相關雜質
      • Thomas Rupp - Owner & Principal, Thomas Rupp Consulting
      9:55am - 10:35am40 分
      Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
      研討會2：長肽和/或複雜肽的製造和表徵
      Analytical Journey of a Peptide Therapeutic: A Tailored Approach
      胜肽藥物的分析之旅：量身訂製的方法
      • Alaric Desmarchelier, PhD - Business Development Manager - Peptides, Almac Group
      10:35am - 11:10am35 分
      Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
      研討會2：長肽和/或複雜肽的製造和表徵
      Networking Refreshment Break
      社交茶歇
        10:40am - 11:15am35 分
        Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
        研討會1：新型RNA化學的相關法規和現實CMC考慮因素
        Networking Refreshment Break
        社交茶歇
          11:10am - 11:50am40 分
          Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
          研討會2：長肽和/或複雜肽的製造和表徵
          Innovations in Preparative Purification of Synthetic Peptides
          合成胜肽製備純化上的創新
          • Marc Jacob, PhD - Head of Strategic Development, Chromatography Products, YMC America
          11:15am - 12:00pm45 分
          Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
          研討會1：新型RNA化學的相關法規和現實CMC考慮因素
          Phase- appropriate CMC Considerations for Next-generation Oligonucleotides
          下一代寡核苷酸階段適宜CMC的考量
          • Pablo Lores Lareo, PhD - CMC Director, Sylentis
          11:50am - 12:30pm40 分
          Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
          研討會2：長肽和/或複雜肽的製造和表徵
          Synthesis Solutions Enabling Rapid Supply of Complex Cyclic Peptides
          能夠快速供應複雜環肽的合成解決方案
          • Manabu Wadamoto, PhD - Chief Scientist, Chugai Pharmaceutical Co., Ltd.
          12:00pm - 12:30pm30 分
          Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
          研討會1：新型RNA化學的相關法規和現實CMC考慮因素
          Panel Discussion and Q&A with Workshop Speakers
          研討會演講嘉賓主持的小組討論與問答
            12:30pm - 1:45pm75 分
            Workshop #1: Regulatory and Practical CMC Considerations Around Novel RNA Chemistries
            研討會1：新型RNA化學的相關法規和現實CMC考慮因素
            Close of Workshop and Luncheon for Morning Workshop Attendees Only
            研討會結束及午餐（僅限上午研討會與會者）
              12:30pm - 1:45pm75 分
              Workshop #2: Manufacturing and Characterization of Long and/or Complex Peptides
              研討會2：長肽和/或複雜肽的製造和表徵
              Close of Workshop and Luncheon for Morning Workshop Attendees Only
              研討會結束及午餐（僅限上午研討會與會者）
                1:45pm - 1:50pm5 分
                Main Conference Plenary Keynote Session
                主要會議 - 全體會議（主題演講）
                Chairperson’s Remarks: Keynote Day 1
                議長致辭：主題演講第1天
                • Yogesh Sanghvi, PhD - President, Rasayan Inc.
                1:50pm - 2:20pm30 分
                Main Conference Plenary Keynote Session
                主要會議 - 全體會議（主題演講）
                Development of New Molecular Technologies for siRNA Therapeutics
                開發siRNA藥物的新分子技術
                • Takeshi Wada, PhD - Professor of Organic Chemistry, Tokyo University of Science
                2:20pm - 2:50pm30 分
                Main Conference Plenary Keynote Session
                主要會議 - 全體會議（主題演講）
                Thiomorpholino Oligonucleotides (TMOs) Useful for Exon Skipping, RNase H and siRNA Applications
                有助於外顯子跳躍、RNase H 和 siRNA 應用的TMO（硫代嗎啡寡核苷酸）
                • Marvin Caruthers, PhD - Distinguished Professor, Biochemistry, University of Colorado
                2:50pm - 3:20pm30 分
                Main Conference Plenary Keynote Session
                主要會議 - 全體會議（主題演講）
                Latest Progress and Advances in RNAi Therapeutics
                RNAi醫藥上的最新進展和發展
                • Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Innovation and Distinguished Research Scientist, Alnylam Pharmaceuticals
                3:20pm - 4:00pm40 分
                Main Conference Plenary Keynote Session
                主要會議 - 全體會議（主題演講）
                Networking Refreshment Break
                社交茶歇
                  4:00pm - 4:30pm30 分
                  Main Conference Plenary Keynote Session
                  主要會議 - 全體會議（主題演講）
                  Emerging Technologies in the Scale Up of Oligonucleotide Therapeutics
                  寡核苷酸醫藥放大生產上的新興技術
                  • Scott May, PhD - VP of Chemistry, Synthetic Molecule Design & Development, Eli Lilly and Company
                  4:30pm - 5:00pm30 分
                  Main Conference Plenary Keynote Session
                  主要會議 - 全體會議（主題演講）
                  Clinical Development of Mazdutide, the First Dual GCG/GLP-1 Receptor Agonist Approval in China, for Chronic Weight Management
                  首個在中國獲準用於慢性體重管理的GCG/GLP-1受體激動劑瑪仕度肽的臨床開發
                  • Lei Qian, MD, PhD - Chief R&D Officer, General Biomedicine, Innoventbio
                  5:00pm - 5:30pm30 分
                  Main Conference Plenary Keynote Session
                  主要會議 - 全體會議（主題演講）
                  The Science Behind the GLP-1 Medicines: A Historic View and Future Outlook
                  GLP-1藥物的科學背景：歷史視角與未來展望
                  • Lotte Bjerre Knudsen, PhD - Chief Scientific Advisor & Head of GLP-1 CoE, Novo Nordisk A/S
                  5:30pm - 5:35pm5 分
                  Main Conference Plenary Keynote Session
                  主要會議 - 全體會議（主題演講）
                  Close of Day One
                  第1天結束

                    * 活動內容有可能不事先告知作更動及調整。

                    Next 主要會議第2天